Arax Advisory Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Arax Advisory Partners’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300	Closed	-$266	–	1320
2022 Q4	$266	Sell	300 -100	-25%	-$133	﹤0.01%	1228
2022 Q3	$1K	Buy	400 +100	+33%	+$227	﹤0.01%	1198
2022 Q2	$1K	Hold	300	–	–	﹤0.01%	1147
2022 Q1	$1K	Hold	300	–	–	﹤0.01%	1140
2021 Q4	$1K	Hold	300	–	–	﹤0.01%	1122
2021 Q3	$2K	Hold	300	–	–	﹤0.01%	863
2021 Q2	$3K	Buy	+300	New	+$2.39K	﹤0.01%	825

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return